Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Structure ; 31(5): 629-638.e5, 2023 05 04.
Article in English | MEDLINE | ID: mdl-36963397

ABSTRACT

Bile salt hydrolases (BSHs) are currently being investigated as target enzymes for metabolic regulators in humans and as growth promoters in farm animals. Understanding structural features underlying substrate specificity is necessary for inhibitor design. Here, we used a multidisciplinary workflow including mass spectrometry, mutagenesis, molecular dynamic simulations, machine learning, and crystallography to demonstrate substrate specificity in Lactobacillus salivarius BSH, the most abundant enzyme in human and farm animal intestines. We show the preference of substrates with a taurine head and a dehydroxylated sterol ring for hydrolysis. A regression model that correlates the relative rates of hydrolysis of various substrates in various enzyme mutants with the residue-substrate interaction energies guided the identification of structural determinants of substrate binding and specificity. In addition, we found T208 from another BSH protomer regulating the hydrolysis. The designed workflow can be used for fast and comprehensive characterization of enzymes with a broad range of substrates.


Subject(s)
Amidohydrolases , Bile Acids and Salts , Animals , Humans , Substrate Specificity , Amidohydrolases/chemistry , Promoter Regions, Genetic , Hydrolysis
2.
Nat Ecol Evol ; 5(6): 708, 2021 06.
Article in English | MEDLINE | ID: mdl-34089024

Subject(s)
Amber , Fossils , Myanmar
3.
FEMS Microbiol Lett ; 367(10)2020 05 01.
Article in English | MEDLINE | ID: mdl-32386211

ABSTRACT

Lactic acid bacterium, Lactobacillus plantarum, has been applied, for centuries, for food and drink fermentations. Given the benefits associated with fermented products, Lb. plantarum strains have captured considerable industrial and scientific interest, so that they are included as fundamental components of functional foods. Indeed, some strains are marketed as probiotics. In the present study, food- and gut-associated Lb. plantarum isolates were genetically characterized by multilocus sequence typing (MLST) and phenotypically characterized for properties that could influence their probiotic potential. MLST and phylogenetic analysis stratified 22 Lb. plantarum isolates into six lineages. The isolates were further phenotypically characterized by an in vitro assay to assess their potential gut community influence via a limited number of assays including acidification activity, strain displacement activity and their intrinsic range of antibiotic resistance. Given growing recognition of the benefits of fermented foods, and the prevalence of Lb. plantarum in these applications, this study highlights analysis of a subset of preliminary important strain-specific features. These features are of interest to all stakeholders, to inform isolate comparison and selection for current functional food associations, and that can serve as a basis for future strain and food-microbe fermentation product development.


Subject(s)
Food Microbiology , Lactobacillus plantarum/classification , Lactobacillus plantarum/genetics , Probiotics , Genotype , Lactobacillus plantarum/isolation & purification , Multilocus Sequence Typing , Phenotype , Phylogeny
4.
Sci Rep ; 10(1): 4941, 2020 03 18.
Article in English | MEDLINE | ID: mdl-32188876

ABSTRACT

Gut microbial enzymes, bile salt hydrolases (BSHs) are the gateway enzymes for bile acid (BA) modification in the gut. This activity is a promising target for developing innovative non-antibiotic growth promoters to enhance animal production and health. Compelling evidence has shown that inhibition of BSH activity should enhance weight gain by altering the BA pool, host signalling and lipid metabolism. We recently identified a panel of promising BSH inhibitors. Here, we address the potential of them as alternative, effective, non-antibiotic feed additives, for commercial application, to promote animal growth using a chicken model. In this study, the in vivo efficacy of three BSH inhibitors (caffeic acid phenethylester, riboflavin, carnosic acid) were evaluated. 7-day old chicks (10 birds/group) were either untreated or they received one of the specific BSH inhibitors (25 mg/kg body weight) via oral gavage for 17 days. The chicks in treatment groups consistently displayed higher body weight gain than the untreated chicks. Metabolomic analysis demonstrated that BSH inhibitor treatment led to significant changes in both circulating and intestinal BA signatures in support of blunted intestinal BSH activity. Consistent with this finding, liver and intestinal tissue RNA-Seq analysis showed that carnosic acid treatment significantly altered expression of genes involved in lipid and bile acid metabolism. Taken together, this study validates microbial BSH activity inhibition as an alternative target and strategy to antibiotic treatment for animal growth promotion.


Subject(s)
Amidohydrolases/antagonists & inhibitors , Bile Acids and Salts/metabolism , Enzyme Inhibitors/pharmacology , Animals , Bile Acids and Salts/blood , Chickens , Drug Discovery , Enzyme Activation/drug effects , Gene Expression Profiling , Gene Expression Regulation/drug effects , Ileum/drug effects , Ileum/metabolism , Liver/drug effects , Liver/metabolism , Metabolic Engineering
5.
BMC Microbiol ; 19(1): 33, 2019 02 08.
Article in English | MEDLINE | ID: mdl-30736731

ABSTRACT

BACKGROUND: Lactobacillus mucosae DPC 6426 has previously demonstrated potentially cardio-protective properties, in the form of dyslipidaemia and hypercholesterolemia correction in an apolipoprotein-E deficient mouse model. This study aims to characterise the manner in which this microbe may modulate host bile pool composition and immune response, in the context of cardiovascular disease. Lactobacillus mucosae DPC 6426 was assessed for bile salt hydrolase activity and specificity. The microbe was compared against several other enteric strains of the same species, as well as a confirmed bile salt hydrolase-active strain, Lactobacillus reuteri APC 2587. RESULTS: Quantitative bile salt hydrolase assays revealed that enzymatic extracts from Lactobacillus reuteri APC 2587 and Lactobacillus mucosae DPC 6426 demonstrate the greatest activity in vitro. Bile acid profiling of porcine and murine bile following incubation with Lactobacillus mucosae DPC 6426 confirmed a preference for hydrolysis of glyco-conjugated bile acids. In addition, the purified exopolysaccharide and secretome of Lactobacillus mucosae DPC 6426 were investigated for immunomodulatory capabilities using RAW264.7 macrophages. Gene expression data revealed that both fractions stimulated increases in interleukin-6 and interleukin-10 gene transcription in the murine macrophages, while the entire secretome was necessary to increase CD206 transcription. Moreover, the exopolysaccharide elicited a dose-dependent increase in nitric oxide and interleukin-10 production from RAW264.7 macrophages, concurrent with increased tumour necrosis factor-α secretion at all doses. CONCLUSIONS: This study indicates that Lactobacillus mucosae DPC 6426 modulates both bile pool composition and immune system tone in a manner which may contribute significantly to the previously identified cardio-protective phenotype.


Subject(s)
Amidohydrolases/biosynthesis , Bile/metabolism , Immunomodulation , Lactobacillus/enzymology , Lactobacillus/immunology , Macrophages/immunology , Animals , Cardiovascular Diseases/immunology , Cardiovascular Diseases/microbiology , Glycosyltransferases/metabolism , Hydrolysis , Interleukin-10/metabolism , Interleukin-6/metabolism , Limosilactobacillus reuteri/enzymology , Lectins, C-Type/metabolism , Macrophages/drug effects , Macrophages/microbiology , Mannose Receptor , Mannose-Binding Lectins/metabolism , Mice , Nitric Oxide/metabolism , Polysaccharides, Bacterial/pharmacology , RAW 264.7 Cells , Receptors, Cell Surface/metabolism , Swine , Tumor Necrosis Factor-alpha/metabolism
6.
Mol Aspects Med ; 56: 54-65, 2017 08.
Article in English | MEDLINE | ID: mdl-28602676

ABSTRACT

Bile acids are synthesized from cholesterol in the liver and released into the intestine to aid the digestion of dietary lipids. The host enzymes that contribute to bile acid synthesis in the liver and the regulatory pathways that influence the composition of the total bile acid pool in the host have been well established. In addition, the gut microbiota provides unique contributions to the diversity of bile acids in the bile acid pool. Gut microbial enzymes contribute significantly to bile acid metabolism through deconjugation and dehydroxylation reactions to generate unconjugated bile acids and secondary bile acids. These microbial enzymes (which include bile salt hydrolase (BSH) and bile acid-inducible (BAI) enzymes) are essential for bile acid homeostasis in the host and represent a vital contribution of the gut microbiome to host health. Perturbation of the gut microbiota in disease states may therefore significantly influence bile acid signatures in the host, especially in the context of gastrointestinal or systemic disease. Given that bile acids are ligands for host cell receptors (including the FXR, TGR5 and Vitamin D Receptor) alterations to microbial enzymes and associated changes to bile acid signatures have significant consequences for the host. In this review we examine the contribution of microbial enzymes to the process of bile acid metabolism in the host and discuss the implications for microbe-host signalling in the context of C. difficile infection, inflammatory bowel disease and other disease states.


Subject(s)
Amidohydrolases/genetics , Bacterial Proteins/genetics , Bile Acids and Salts/metabolism , Gastrointestinal Microbiome/physiology , Host-Pathogen Interactions , NADH, NADPH Oxidoreductases/genetics , Amidohydrolases/metabolism , Animals , Bacterial Proteins/metabolism , Biotransformation , Clostridioides difficile/metabolism , Clostridioides difficile/pathogenicity , Enterocolitis, Pseudomembranous/metabolism , Enterocolitis, Pseudomembranous/microbiology , Enterocolitis, Pseudomembranous/pathology , Gene Expression Regulation , Homeostasis/physiology , Humans , Intestinal Mucosa/metabolism , Intestines/microbiology , Liver/cytology , Liver/metabolism , NADH, NADPH Oxidoreductases/metabolism , Receptors, Calcitriol/genetics , Receptors, Calcitriol/metabolism , Receptors, Cytoplasmic and Nuclear/genetics , Receptors, Cytoplasmic and Nuclear/metabolism , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...